文献速递乳腺癌放疗

乳腺癌放射治疗中的剂量限值:一项批判性综述

Dose constraints in breast cancer radiotherapy. A critical review.
PubMed 文献 · Radiother Oncol · 2024-10-19

本批判性综述汇总了适用于全乳/胸壁放疗、全乳/胸壁放疗联合区域淋巴结照射及部分乳腺照射的危及器官剂量-体积限值证据,涵盖IMRT、VMAT、DIBH及中度/超中度低分次方案等新技术背景,旨在帮助统一治疗计划策略。

要点

  • 近三十年IMRT、VMAT、DIBH及低分次方案和部分乳腺照射显著改变了乳腺癌放疗实践。
  • 剂量-体积限值需适应新的治疗模式,本文综述了主要危及器官的循证剂量限值数据。
  • 综述覆盖全乳/胸壁放疗、联合区域淋巴结照射及部分乳腺照射的近期分次方案。

核心结论

  • 本叙述性综述提供了 comprehensive 总结,可能有助于统一治疗计划策略。

研究设计与样本

  • 叙述性综述,复习了适用于全乳/胸壁放疗、全乳/胸壁放疗联合区域淋巴结照射及部分乳腺照射的危及器官剂量-体积限值证据。

主要发现

  • IMRT、VMAT、DIBH技术及中度低分次、超低分次方案和部分乳腺照射的应用显著改变了乳腺癌放疗。
  • 剂量-体积限值需适应这些新治疗模式。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiotherapy plays an essential role in the treatment of breast cancer (BC). Recent advances in treatment technology and radiobiological knowledge have a major impact in BC patients with locoregional disease as the majority are now long-term survivors. Over the last three decades, intensity-modulated radiotherapy (IMRT), volumetric-modulated arc therapy (VMAT) and deep inspiration breath-hold (DIBH) techniques, together with the increasing adoption of moderately hypofractionated and ultra-hypofractionated treatment schedules as well as the possibility to offer partial breast radiotherapy to a well-defined patient subset have significantly changed radiotherapy for BC patients. As dose-volume constraints (DVCs) have to be adapted to these new treatment paradigms we have reviewed available evidence-based data concerning dose-constraints for the main organs at risk (OARs) that apply to the treatment of whole breast/chest wall radiotherapy, whole breast/chest wall radiotherapy including regional nodal irradiation (RNI) and partial breast irradiation (PBI), for the most relevant fractionation schedules that have been introduced recently. This narrative review provides a comprehensive summary that may help to harmonize treatment planning strategies.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. De Rose F, Carmen De Santis M, Lucidi S, et al. Dose constraints in breast cancer radiotherapy. A critical review. Radiother Oncol. 2024. PMID: 39427931. doi:10.1016/j.radonc.2024.110591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。